![]()
|
|
||||||||
(Received for publication, July 22, 1996, and in revised form, August 19, 1996)
From the Anti-Müllerian hormone, a member of the
transforming growth factor
Volume 271, Number 48,
Issue of November 29, 1996
pp. 30571-30575
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
,
,
,
,
and
Unité de Recherches sur
l'Endocrinologie du Développement (INSERM), Ecole Normale
Supérieure, Département de Biologie, 1 rue Maurice-Arnoux,
92120 Montrouge, France and § Biogen Inc., Cambridge,
Massachusetts 02142
superfamily, produces early regression
of Müllerian ducts in the male fetus through binding to a
serine/threonine kinase receptor, homologous to type II receptors of
the transforming growth factor
(TGF-
) family. A splice mutation
of this receptor, described in a patient with abnormal retention of
Müllerian derivatives, generates two mutant isoforms, one lacking
the second exon and the other bearing an insertion of 12 bases between
exons 2 and 3. Using hemagglutinin-tagged recombinant receptors, we
have visualized wild type and mutant receptors in COS cells by Western
blotting and immunoprecipitation. The 82-kDa, endoglycosidase
H-insensitive, mature form of the wild type receptor is reduced to 68 kDa by N-glycosidase F treatment. Mutant receptor isoforms,
73 and 63 kDa for the long and short form, respectively, are sensitive
to endoglycosidase H, suggesting that they are retained in the
endoplasmic reticulum. Indeed, only the wild type receptor was
expressed on the cell surface and bound iodinated anti-Müllerian
hormone. These results provide a biological explanation for the failure of the mutant receptor to induce Müllerian regression.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
N. Josso, C. Belville, N. di Clemente, and J.-Y. Picard AMH and AMH receptor defects in persistent Mullerian duct syndrome Hum. Reprod. Update, July 1, 2005; 11(4): 351 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Belville, H. Van Vlijmen, C. Ehrenfels, B. Pepinsky, A. R. Rezaie, J.-Y. Picard, N. Josso, N. d. Clemente, and R. L. Cate Mutations of the Anti-Mullerian Hormone Gene in Patients with Persistent Mullerian Duct Syndrome: Biosynthesis, Secretion, and Processing of the Abnormal Proteins and Analysis Using a Three-Dimensional Model Mol. Endocrinol., March 1, 2004; 18(3): 708 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Messika-Zeitoun, L. Gouedard, C. Belville, M. Dutertre, L. Lins, S. Imbeaud, I. A. Hughes, J.-Y. Picard, N. Josso, and N. di Clemente Autosomal Recessive Segregation of a Truncating Mutation of Anti-Mullerian Type II Receptor in a Family Affected by the Persistent Mullerian Duct Syndrome Contrasts with Its Dominant Negative Activity in Vitro J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4390 - 4397. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gouedard, Y.-G. Chen, L. Thevenet, C. Racine, S. Borie, I. Lamarre, N. Josso, J. Massague, and N. di Clemente Engagement of Bone Morphogenetic Protein Type IB Receptor and Smad1 Signaling by Anti-Mullerian Hormone and Its Type II Receptor J. Biol. Chem., September 1, 2000; 275(36): 27973 - 27978. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |